Your search returned 23 results.

Results
	21.	Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. [electronic resource] by Bores, G M Huger, F P Petko, W Mutlib, A E Camacho, F Rush, D K Selk, D E Wolf, V Kosley, R W Davis, L Vargas, H M Producer: 19960627 In: The Journal of pharmacology and experimental therapeutics vol. 277 Availability: No items available. Save to lists Add to cart (remove)
	22.	3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia. [electronic resource] by Hrib, N J Jurcak, J G Bregna, D E Dunn, R W Geyer, H M Hartman, H B Roehr, J E Rogers, K L Rush, D K Szczepanik, A M Producer: 19920826 In: Journal of medicinal chemistry vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. [electronic resource] by Smith, C P Bores, G M Petko, W Li, M Selk, D E Rush, D K Camacho, F Winslow, J T Fishkin, R Cunningham, D M Brooks, K M Roehr, J Hartman, H B Davis, L Vargas, H M Producer: 19970317 In: The Journal of pharmacology and experimental therapeutics vol. 280 Availability: No items available. Save to lists Add to cart (remove)

Refine your search